United-Guardian Reports Increased First Quarter Sales & Earnings
May 10, 2024 15:00 ET
|
United-Guardian, Inc.
HAUPPAUGE, N.Y., May 10, 2024 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) announced today the financial results for the first quarter of 2024. First quarter sales increased from $2,570,324...
Optinose Announces Reporting Date for First Quarter 2024 Financial Results
May 10, 2024 14:56 ET
|
Optinose, Inc.
YARDLEY, Pa., May 10, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the...
NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14
May 10, 2024 14:43 ET
|
NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., May 10, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
Verizon to speak at MoffettNathanson conference May 14
May 10, 2024 14:00 ET
|
Verizon Sourcing LLC
NEW YORK, May 10, 2024 (GLOBE NEWSWIRE) -- Sowmyanarayan Sampath, executive vice president for Verizon (NYSE, Nasdaq: VZ), and CEO for Verizon Consumer, is scheduled to speak at the MoffettNathanson...
ContextLogic Announces Ticker Symbol Will Change to LOGC on May 13, 2024
May 10, 2024 12:52 ET
|
ContextLogic Inc.
OAKLAND, Calif., May 10, 2024 (GLOBE NEWSWIRE) -- ContextLogic Inc. (NASDAQ: WISH) today announced that its Class A common stock will begin trading on NASDAQ under the ticker symbol “LOGC” prior to...
Merus gibt Finanzergebnisse für das erste Quartal 2024 bekannt und informiert über den aktuellen Geschäftsverlauf
May 10, 2024 12:36 ET
|
Merus N.V.
Petosemtamab in Kombination mit Pembrolizumab bei 1L (Erstlinientherapie) HNSCC – erste vorläufige klinische Daten auf der ASCO-Jahrestagung 2024; Vorbereitung einer möglichen Phase-III-StudieZeno-BLA...
Merus annonce ses résultats financiers pour le premier trimestre 2024 et fait le point sur ses activités
May 10, 2024 12:36 ET
|
Merus N.V.
Données cliniques intermédiaires initiales concernant le pétosemtamab en association avec le pembrolizumab en traitement de 1re ligne du CETC présentées lors du congrès annuel de l’ASCO 2024 ;...
Statement from FAT Brands Regarding SOX 402 Charges
May 10, 2024 11:52 ET
|
FAT Brands Inc.
LOS ANGELES, May 10, 2024 (GLOBE NEWSWIRE) -- Today Brian Hennigan of Hueston Hennigan LLP, Counsel for FAT Brands Inc., issued the following statement: “Today FAT Brands was informed that it has...
Mingteng International Corporation Inc. Announces Full Exercise of Underwriters’ Over-Allotment Option
May 10, 2024 11:25 ET
|
Mingteng International Corporation Inc.
Wuxi, China, May 10, 2024 (GLOBE NEWSWIRE) -- Mingteng International Corporation Inc. (the “Company” or “Mingteng International”) (Nasdaq: MTEN), an automotive mold developer and supplier in China,...
POET Announces Closing of Private Placement Financing for CAD$10 Million
May 10, 2024 10:28 ET
|
POET Technologies Inc.
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, May 10, 2024 (GLOBE NEWSWIRE) -- POET Technologies Inc. (“POET” or the “Company”) (TSX...